AstraZeneca Pharmaceuticals LP recalls Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only.…
- Recall date
- February 5, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0781-2016
- FDA classification
- Class II
- Brand / firm
- AstraZeneca Pharmaceuticals LP
- Sold / distributed
- US: Nationwide Including Puerto Rico
Why it was recalled
Defective Delivery System: Some units have actuation counters set to a number other than 60.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.
Get recall alerts
Free email alert whenever AstraZeneca Pharmaceuticals LP has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AstraZeneca Pharmaceuticals LP